Condition
Anaphylaxis Food
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed with results
Key Signals
2 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Completed3
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05696236Not ApplicableCompletedPrimary
Predicting Peanut Anaphylaxis and Reducing Epinephrine
NCT07045701Phase 2Enrolling By InvitationPrimary
FMXIN002 in Patients at Risk of Anaphylaxis
NCT03149315Phase 2Completed
Inhibition of Anaphylaxis by Ibrutinib
NCT03487315Not ApplicableCompleted
Major Allergen in Wheat Anaphylaxis in Thai Population
Showing all 4 trials